Amphetamine vs Methylphenidate October 5, 2022 Chris Aiken, MD Clinicians should understand how amphetamine and methylphenidate differ in respect to their: risks of psychosis, mania, and substance use, neurotoxic and neuroprotective properties, efficacy and tolerability, and use across the lifespan.Read More
CARLAT WEBINAR Treatment of Depression During Pregnancy September 13, 2022 Victoria Hendrick, MD How to have a discussion with patients and to document risks and benefits to educate them the baseline risk of depression treatment in pregnancy. Read More
General PsychiatryMDMA: What Went Wrong Part 2Did boundary violations sink MDMA-assisted therapy, or was there something more? In part II of our series, we look at what else went wrong.Listen now